![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Cyclosporine (1)
02 Terazosin hydrochloride (1)
03 Upadacitinib hemihydrate (1)
04 Venetoclax (1)
05 glecaprevir (2)
06 pibrentasvir (1)
01 AbbVie Korea Co., Ltd. (6)
02 Ilyang Pharmaceutical Co., Ltd. (1)
01 AbbVie Inc. (1)
02 AbbVie Ireland NL BV (3)
03 [Manufacture of Intermediate 3 and API] AbbVie Srl@[Manufacture of Intermediate L and Intermediate 2] Jilin Asymchem Laboratories Co., Ltd@[Manufacture of Intermediate 1] Lundbeck Pharmaceuticals Italy SpA (1)
04 [Manufacture of Intermediate 3 and API] Abbvie Ireland NL BV@[Manufacture of Intermediate 1] Lundbeck Pharmaceuticals Italy SpA@[Manufacture of Intermediate L and Intermediate 2] Jilin Asymchem Laboratories Co., Ltd (1)
05 [Raw drug product manufacturing] Abbvie Ireland NL BV@[Intermediate 1-5 manufacturing] Procos SpA (1)
01 Ireland (3)
02 U.S.A (4)